leisure time -WSS

leisure time

author：comprehensive 2025-09-06 04:38:22 - browse：835

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

In an abrupt change of course from plans earlier in the month, at-home test maker Cue Health is laying off all of its employees and shutting down as of Friday, May 24.

The company, which grew to prominence during the Covid-19 pandemic as the maker of one of the only molecular at-home tests for the virus, has been teetering on the edge of insolvency for months. The shutdown, first reported by the San Diego Union-Tribune, comes just over a week after the FDA warned consumers not to use Cue’s only FDA-authorized product, a Covid-19 test kit.

Cue had previously notified 49% of its workers on May 1 that they would be laid off from the company, effective July 1. But in a WARN notice filed with California state regulators on May 20, chief human resources officer Allison Blackwell said that due to the “fluid nature of this situation,” all U.S. employees who had not already received notice of termination would be receiving one. All employees will receive their last paychecks on May 24, the notice said.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Empower primary care with adequate payments and technology

focus

WSS

Is it ever OK for doctors to lie to their patients?

Think you might have Covid

Medicare Advantage today, explained in one chart

FDA clears AI tool for detecting skin cancer

Why doctors need education on FDA device approval process

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

AltruBio raises $225 million to develop ulcerative colitis drug

At least 13 dead in Texas as scorching temps continue

Lawmakers grill UnitedHealth CEO on Change cyberattack

Drug repurposing or repositioning? The language matters

Has Bernie Sanders reached the limit of his pharma bullying effort?

Alkermes shareholders re

Test for long Covid? Researchers find new clue in blood samples

Drug repurposing or repositioning? The language matters

My yearlong odyssey to get my son’s ADHD medication covered

hotspot

eGenesis tests gene

As health system earnings go up, health insurance stocks go down

Brain MRIs reveal impact of 'toxic stress' on Black children

Readout Newsletter: Merck, J&J, and long Covid

EU regulator recommends expanding Mounjaro approval to obesity

New brain studies show LSD's effects on the brain in full color

knowledge

explore

focus

entertainment